Q3 2023 Holdings
Filed 2023-11-14 | 75 holdings | $321.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr S&P Biotech ETF(XBI) | ETF | 78464A870 | $41.3M | 565,000 | 12.8% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $21.6M | 13,680,554 | 6.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $14.1M | 479,538 | 4.4% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $13.5M | 499,820 | 4.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $13.1M | 473,394 | 4.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $12.8M | 136,212 | 4.0% |
| Ishares Nasdaq Biotech Indx(IBB) | ETF | 464287556 | $12.5M | 102,500 | 3.9% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $12.5M | 249,521 | 3.9% |
| Merus N V | COM | N5749R100 | $11.4M | 484,870 | 3.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $9.6M | 280,538 | 3.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $8.9M | 52,873 | 2.8% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $8.3M | 73,615 | 2.6% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $7.2M | 586,463 | 2.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $6.7M | 458,373 | 2.1% |
| Dexcom Inc(DXCM) | COM | 252131107 | $6.3M | 67,552 | 2.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $5.8M | 605,532 | 1.8% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $5.7M | 1,447,465 | 1.8% |
| Atricure Inc(ATRC) | COM | 04963C209 | $5.5M | 125,529 | 1.7% |
| Morphic Holding Inc | COM | 61775R105 | $5.3M | 231,748 | 1.7% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $5.0M | 550,784 | 1.6% |
| Axogen Inc(AXGN) | COM | 05463X106 | $4.7M | 935,894 | 1.5% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $4.6M | 652,000 | 1.4% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $4.6M | 220,708 | 1.4% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $4.4M | 556,695 | 1.4% |
| Alector Inc(ALEC) | COM | 014442107 | $4.1M | 628,938 | 1.3% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $4.0M | 92,887 | 1.3% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $4.0M | 222,717 | 1.2% |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | $3.7M | $4,000,000 | 1.1% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $3.5M | 319,655 | 1.1% |
| Accuray Inc(ARAY) | COM | 004397105 | $3.3M | 1,222,358 | 1.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $3.0M | 519,384 | 0.9% |
| Mediwound LTD(MDWD) | SHS NEW | M68830112 | $2.7M | 257,653 | 0.9% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $2.6M | 1,307,407 | 0.8% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $2.5M | 122,200 | 0.8% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $2.2M | 122,547 | 0.7% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $2.2M | 67,300 | 0.7% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $2.2M | 295,493 | 0.7% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $2.2M | 928,253 | 0.7% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $2.1M | 65,961 | 0.7% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $2.1M | 60,175 | 0.6% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $1.9M | 300,000 | 0.6% |
| Brainsway LTD(BWAY) | SPONSORED ADS | 10501L106 | $1.7M | 432,181 | 0.5% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $1.5M | 1,111,049 | 0.5% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $1.4M | 193,000 | 0.4% |
| Cerevel Therapeutics Holdings Inc(CERE1EUR) | COM | 15678U128 | $1.4M | 62,200 | 0.4% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $1.3M | 83,000 | 0.4% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $1.3M | 327,373 | 0.4% |
| Spruce Biosciences Inc | COM | 85209E109 | $1.3M | 570,130 | 0.4% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $1.2M | 962,513 | 0.4% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $1.2M | 1,476,052 | 0.4% |